The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation☆
Abstract
OBJECTIVE: Reactive oxygen species (ROS) produced by NAD(P)H oxidases (Nox) play a significant role in the pathophysiology of cardiovascular diseases. Expression and activity of NAD(P)H oxidases are regulated by growth factors such as angiotensin II and platelet-derived growth factor (PDGF). We characterized the effects of the novel Nox inhibitor VAS2870 on PDGF-dependent ROS liberation and cellular events in vascular smooth muscle cells (VSMC). METHODS AND RESULTS: PDGF-BB increased NAD(P)H oxidase activity (lucigenin-enhanced chemiluminescence) and intracellular ROS levels (detected by confocal laserscanning microscopy using 2,7-DCF) to 229+/-9% and 362+/-54% at 1 and 2 h, respectively. Preincubation with VAS2870 (10 and 20 microM) completely abolished PDGF-mediated NAD(P)H oxidase activation and ROS production. Since ROS are involved in various growth factor-induced cellular functions, the influence of VAS2870 on PDGF-induced DNA synthesis and chemotaxis was determined. PDGF promoted a 4.2+/-0.2-fold increase of VSMC migration (modified Boyden chamber, p<0.01) and increased DNA synthesis by maximally 3.2+/-0.4-fold (BrdU incorporation, p<0.01) in a concentration-dependent manner. Preincubation with VAS2870 (0.1-20 microM) did not affect PDGF-induced cell cycle progression. However, it abolished PDGF-dependent chemotaxis of VSMC in a concentration-dependent manner (100% inhibition at 10 microM). These findings were related to PDGF-dependent signaling events. Western blot analyses using phospho-specific antibodies revealed that the downstream signaling molecules Akt, Erk, and Src were activated by PDGF. However, VAS2870 blocked PDGF-dependent activation of Src, but not of Akt and Erk, in a concentration-dependent manner. CONCLUSIONS: VAS2870 effectively suppresses growth factor-mediated ROS liberation in VSMC. Furthermore, it completely inhibits PDGF-dependent VSMC migration, whereas it does not affect DNA synthesis. These divergent effects reflect the critical role of Src activity, which-in contrast to Akt and Erk-appears to be redox-sensitive and is absolutely required for PDGF-induced chemotaxis, but not cell cycle progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This scheme has been found to apply to virtually all the heme protein–mediated nitrite reduction reactions studied to date, including Hb (248, 447), Mb (247, 862), neuroglobin (Ngb) (932, 945), Cygb (182, 571, 780), cystathionine β-synthase (CBS) (149, 350), globin X (184), plant and cyanobacterial Hb (phytohemoglobins) (905, 946), flavohemoglobin (340), heme-albumin (43), cytochrome c (41), prot”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [932]
In the citing paper
“It was recently demonstrated that, as observed with other globins, deoxygenated Ngb can also reduce nitrite to NO (932, 945).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [932]
In the citing paper
“However, although initial experiments suggested VAS2870 to be Nox2-specific, it is definitely not [341,393,403,404].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [404]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
Requirement for Generation of H 2 O 2 for Platelet-Derived Growth Factor Signal Transduction
Sundaresan, M., Yu, Z.-X., Ferrans, V. J., Irani, K., & Finkel, T. (1995) · Science · doi:10.1126/science.270.5234.296 · Cited by 2,520
The smooth muscle cell in culture
Chamley-Campbell, J. H., CAMPBELL, G. R., & Ross, R. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.1.1 · Cited by 1,560
Cell transformation by the superoxide-generating oxidase Mox1
Suh, Y.-A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., & Lambeth, J. D. (1999) · Nature · doi:10.1038/43459 · Cited by 1,480
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassegue, B. P., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,026
Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis
Sorescu, D., Weiss, D., Lassègue, B., Clempus, R. E., Szöcs, K., Sorescu, G. P., Valppu, L., Quinn, M. T., Lambeth, J. D., Vega, J. D., et al. (2002) · Circulation · doi:10.1161/01.cir.0000012917.74432.66 · Cited by 847
Identification of Renox, an NAD(P)H oxidase in kidney
Geiszt, M., Kopp, J. B., Várnai, P., & Leto, T. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130135897 · Cited by 840
Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839
Homologs of gp91 phox : cloning and tissue expression of Nox3, Nox4, and Nox5
Cheng, G., Cao, Z., Xu, X., Meir, E. G. V., & Lambeth, J. D. (2001) · Gene · doi:10.1016/s0378-1119(01)00449-8 · Cited by 820
The superoxide-generating NADPH oxidase: structural aspects and activation mechanism
Vignais, P. V. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8520-9 · Cited by 799
Research works printed but not linked: 1
- Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal trans- duction. Science 1995;270:296 -9.
Cited by
Sorted by citations
A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish
Niethammer, P., Grabher, C., Look, A. T., & Mitchison, T. J. (2009) · Nature · doi:10.1038/nature08119 · Cited by 1,541
NADPH oxidases: An overview from structure to innate immunity-associated pathologies
Panday, A., Sahoo, M. K., Osorio, D., & Batra, S. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2014.89 · Cited by 944
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3403 · Cited by 899
Oxidative Stress and Pathophysiology of Ischemic Stroke: Novel Therapeutic Opportunities
Rodrigo, R., Fernández-Gajardo, R., Gutiérrez, R., Matamala, J. M., Carrasco, R. A., Miranda-Merchak, A., & Walter Feuerhake, M. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312050015 · Cited by 649
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Zhang, Y., Murugesan, P., Huang, K., & Cai, H. “. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 551
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521
Self-citationNADPH Oxidases in Vascular Pathology
Konior, A., Schramm‐Luc, A., Cześnikiewicz‐Guzik, M., & Guzik, T. J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5607 · Cited by 464
Kleinschnitz, C., Grund, H., Wingler, K., Armitage, M. E., Jones, E., Mittal, M., Barit, D., Schwarz, T., Geis, C., Kraft, P., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000479 · Cited by 447
Self-citationNADPH oxidase in brain injury and neurodegenerative disorders
Ma, M. W., Wang, J., Zhang, Q., Wang, R., Dhandapani, K. M., Vadlamudi, R. K., & Brann, D. W. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0150-7 · Cited by 432
The NOX toolbox: validating the role of NADPH oxidases in physiology and disease
Altenhöfer, S., Kleikers, P. W. M., Radermacher, K. A., Scheurer, P., Rob Hermans, J. J., Schiffers, P., Ho, H., Wingler, K., & Schmidt, H. H. H. W. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1010-9 · Cited by 371
Self-citationBasic Mechanisms of Oxidative Stress and Reactive Oxygen Species in Cardiovascular Injury
Papaharalambus, C. A., & Griendling, K. K. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2006.11.005 · Cited by 351
Hervera, A., Virgiliis, F. D., Palmisano, I., Zhou, L., Tantardini, E., Kong, G., Hutson, T. H., Danzi, M. C., Perry, R. B., Santos, C. X. C., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0039-x · Cited by 336
Role of reactive oxygen and nitrogen species in the vascular responses to inflammation
Kvietys, P. R., & Granger, D. N. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.002 · Cited by 319
Vascular Oxidative Stress: Impact and Therapeutic Approaches
Sena, C. M., Leandro, A., Azul, L., Seiça, R. M. F., & Perry, G. L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01668 · Cited by 266
Small-Molecule NOX Inhibitors: ROS-Generating NADPH Oxidases as Therapeutic Targets
Jaquet, V., Scapozza, L., Clark, R. A., Krause, K. H., & Lambeth, J. D. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2585 · Cited by 245
Diaz, B., Shani, G., Pass, I., Anderson, D., Quintavalle, M., & Courtneidge, S. A. (2009) · Science Signaling · doi:10.1126/scisignal.2000368 · Cited by 242
Redox Signaling, Vascular Function, and Hypertension
Lee, M. Y., & Griendling, K. K. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1986 · Cited by 249
Selemidis, S., Sobey, C. G., Wingler, K., Schmidt, H. H. H. W., & Drummond, G. R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.005 · Cited by 249
Self-citationComparative pharmacology of chemically distinct nadph oxidase inhibitors
Wind, S., Beuerlein, K., Eucker, T., Müller, H., Scheurer, P., Armitage, M., Ho, H., Schmidt, H., & Wingler, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00920.x · Cited by 241
Self-citationMechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension
Li, Q., Youn, J.-Y., & Cai, H. “. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000587 · Cited by 244
CaMKII in the Cardiovascular System: Sensing Redox States
Erickson, J. R., He, B. J., Grumbach, I. M., & Anderson, M. E. (2011) · Physiological Reviews · doi:10.1152/physrev.00018.2010 · Cited by 244
Lee, M. Y., Martín, A. S., Mehta, P. K., Dikalova, A., Garrido, A. M., Datla, S. R., Lyons, E., Krause, K., Bánfi, B., Lambeth, J. D., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.181925 · Cited by 239
Targeting NADPH oxidases in vascular pharmacology
Schramm‐Luc, A., Matusik, P. T., Osmenda, G., & Guzik, T. J. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.012 · Cited by 233
Hydrogen Peroxide as a Signaling Molecule
Veal, E. A., & Day, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3968 · Cited by 217
Nox enzymes as novel targets for drug development
Lambeth, J. D., Krause, K.-H., & Clark, R. A. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0123-6 · Cited by 212
Rauf, A., Khalil, A. A., Awadallah, S. M., Khan, S. A., Abu‐Izneid, T., Kamran, M., Hemeg, H. A., Mubarak, M. S., Khalid, A., & Wilairatana, P. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3784 · Cited by 220
Pharmacological characterization of the seven human NOX isoforms and their inhibitors
Augsburger, F., Филиппова, А., Rasti, D., Seredenina, T. S., Lam, M. A., Maghzal, G. J., Mahiout, Z., Jansen‐Dürr, P., Knaus, U. G., Doroshow, J. H., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101272 · Cited by 198
NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors
Cipriano, A., Viviano, M., Feoli, A., Milite, C., Sarno, G., Castellano, S., & Sbardella, G. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00770 · Cited by 208
Wind, S., Beuerlein, K., Armitage, M. E., Taye, A., Kumar, A. H. S., Janowitz, D., Neff, C., Shah, A. M., Wingler, K., & Schmidt, H. H. H. W. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.149187 · Cited by 181
Self-citationPatten, D. A., Lafleur, V. N., Robitaille, G. A., Chan, D. A., Giaccia, A. J., & Richard, D. E. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-01-0025 · Cited by 171
NADPH oxidase family proteins: signaling dynamics to disease management
Begum, R., Thota, S., Abdulkadir, A. S., Kaur, G., Bagam, P., & Batra, S. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00858-1 · Cited by 164
Neuroprotection After Stroke by Targeting NOX4 As a Source of Oxidative Stress
Radermacher, K. A., Wingler, K., Langhauser, F., Altenhöfer, S., Kleikers, P. W. M., Hermans, J. J. R., de Angelis, M. H., Kleinschnitz, C., & Schmidt, H. H. H. W. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4797 · Cited by 147
Self-citationThe nox4 inhibitor gkt137831 attenuates hypoxia-induced pulmonary vascular cell proliferation
Green, D. E., Murphy, T. C., Kang, B.-Y., Kleinhenz, J. M., Szyndralewiez, C., Page, P., Sutliff, R. L., & Hart, C. M. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0418oc · Cited by 146
NADPH Oxidase Inhibitors: New Antihypertensive Agents?
Williams, H. C., & Griendling, K. K. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318063e820 · Cited by 146
Redox Control of Renal Function and Hypertension
Nistala, R., Whaley‐Connell, A. T., & Sowers, J. R. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2034 · Cited by 147
NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?
Sahoo, S., Meijles, D. N., & Pagano, P. J. (2016) · Clinical Science · doi:10.1042/cs20150087 · Cited by 147
Oxidative stress in chronic vascular disease: From prediction to prevention
Santilli, F., D’Ardes, D., & Davì, G. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.09.003 · Cited by 143
NADPH oxidases as therapeutic targets in ischemic stroke
Kahles, T., & Brandes, R. P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1011-8 · Cited by 138
Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis
Estornut, C., Milara, J., Bayarri, M. A., Belhadj, N., & Cortijo, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.794997 · Cited by 138
The NADPH Oxidase Family and its Inhibitors
Kleniewska, P., Piechota-Polańczyk, A., Skibska, B., & Gorąca, A. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0176-z · Cited by 131
Redox regulation of the actin cytoskeleton and its role in the vascular system
Xu, Q., Huff, L. P., Fujii, M., & Griendling, K. K. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.03.004 · Cited by 132
Src redox regulation: Again in the front line
Giannoni, E., Taddei, M. L., & Chiarugi, P. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.04.025 · Cited by 120
Kreisel, D., Sugimoto, S., Zhu, J., Nava, R. G., Li, W., Okazaki, M., YAMAMOTO, S., Ibrahim, M., Huang, H. J., Toth, K. A., et al. (2011) · Blood · doi:10.1182/blood-2011-04-347823 · Cited by 119
Oxidative Stress, Nox Isoforms and Complications of Diabetes—Potential Targets for Novel Therapies
Sedeek, M. H., Montezano, A. C. I., Hébert, R., Gray, S. P., Marco, E. D., Jha, J. C., Cooper, M. E., Jandeleit-Dahm, K. A. M., Schiffrin, E. L., Wilkinson‐Berka, J. L., et al. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9387-2 · Cited by 120
Wang, L., Yu, T., Lee, H., O'Brien, D. K., Sesaki, H., & Yoon, Y. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv005 · Cited by 121
Nox1, 2, 4, 5: Counting out oxidative stress
Wingler, K., Hermans, J., Schiffers, P., Moens, A., Paul, M., & Schmidt, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01249.x · Cited by 113
Self-citationUpdates of reactive oxygen species in melanoma etiology and progression
Liu, F., Dellinger, R. W., & Meyskens, F. L. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.04.007 · Cited by 119
Biomechanical Strain Exacerbates Inflammation on a Progeria‐on‐a‐Chip Model
Ribas, J., Zhang, Y. S., Pitrez, P. R., Leijten, J., Miscuglio, M., Rouwkema, J., Dokmeci, M. R., Nissan, X., Ferreira, L., & Khademhosseini, A. (2017) · Small · doi:10.1002/smll.201603737 · Cited by 118
TRPM2 dependence of ROS-induced NLRP3 activation in Alzheimer's disease
Aminzadeh, M., Roghani, M., Sarfallah, A., & Riazi, G. H. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.10.024 · Cited by 110
Teixeira-Santos, L., Albino‐Teixeira, A., & Pinho, D. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105280 · Cited by 108
NADPH oxidases: redox regulation of cell homeostasis and disease
Kračun, D., Lopes, L. R., Cifuentes-Pagano, E., & Pagano, P. J. (2025) · Physiological Reviews · doi:10.1152/physrev.00034.2023 · Cited by 114
NADPH oxidases: Current aspects and tools
Schröder, K. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101512 · Cited by 110
Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?
Silva, T. M. D., & Miller, A. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00061 · Cited by 105
Efimova, O., Szankasi, P., & Kelley, T. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016013 · Cited by 103
DeVallance, E., Li, Y., Jurczak, M. J., Cifuentes-Pagano, E., & Pagano, P. J. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7674 · Cited by 103
NADPH Oxidases as Regulators of Tumor Angiogenesis: Current and Emerging Concepts
Coso, S., Harrison, I., Harrison, C. B., Vinh, A., Sobey, C. G., Drummond, G. R., Williams, E. D., & Selemidis, S. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4489 · Cited by 101
Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy
Lindblom, R. S. J., Higgins, G. C., Coughlan, M. T., & de Haan, J. B. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.134 · Cited by 99
NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress
Diebold, B. A., Smith, S. M., Yang, L., & Lambeth, J. D. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5862 · Cited by 99
Lange, S., Heger, J., Euler, G., Wartenberg, M., Piper, H. M., & Sauer, H. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn258 · Cited by 97
Self-citationThe role of NOX inhibitors in neurodegenerative diseases
Barua, S., Kim, J. Y., Yenari, M. A., & Lee, J. E. (2019) · IBRO Reports · doi:10.1016/j.ibror.2019.07.1721 · Cited by 91
NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS
Cifuentes-Pagano, E., Csányi, G., & Pagano, P. J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1009-2 · Cited by 94
ten Freyhaus, H., Dagnell, M., Leuchs, M., Vantler, M., Berghausen, E. M., Caglayan, E., Weißmann, N., Dahal, B. K., SCHERMULY, R. T., Östman, A., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200911-1663oc · Cited by 91
Self-citationNOXious signaling in pain processing
Kallenborn-Gerhardt, W., Schröder, K., Geißlinger, G., & Schmidtko, A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.001 · Cited by 93
Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition
Schluter, T., Steinbach, A. C., Steffen, A., Rettig, R., & Grisk, O. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn185 · Cited by 90
The NADPH Oxidase Family and Its Inhibitors
Chocry, M., & Leloup, L. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7915 · Cited by 91
Bitar, M. S., & Al‐Mulla, F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00047.2011 · Cited by 89
Pharmacology and Clinical Drug Candidates in Redox Medicine
Dao, V. T.-V., Casas, A. I., Maghzal, G. J., Seredenina, T., Kaludercic, N., Robledinos-Anton, N., Di Lisa, F., Stocker, R., Ghezzi, P., Jaquet, V., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6430 · Cited by 88
Reactive Oxygen Species: Not Omnipresent but Important in Many Locations
Herb, M., Gluschko, A., & Schramm, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716406 · Cited by 93
Bäumer, A. T., ten Freyhaus, H., Sauer, H., Wartenberg, M., Kappert, K., Schnabel, P., Konkol, C., Hescheler, J., Vantler, M., & Rosenkranz, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704997200 · Cited by 87
Self-citationRedox Control of Vascular Smooth Muscle Migration
Martín, A. S., & Griendling, K. K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2852 · Cited by 87
Reactive oxygen species and erectile dysfunction: possible role of NADPH oxidase
Jeremy, J. Y., Jones, R. A., Koupparis, A. J., Hotston, M. R., Persad, R. A., Angelini, G. D., & Shukla, N. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901523 · Cited by 86
Are reactive oxygen species still the basis for diabetic complications?
Marco, E. D., Jha, J. C., Sharma, A., Wilkinson‐Berka, J. L., Jandeleit-Dahm, K. A. M., & de Haan, J. B. (2015) · Clinical Science · doi:10.1042/cs20150093 · Cited by 86
Linking RAGE and Nox in diabetic micro- and macrovascular complications
Koulis, C., Watson, A. M. D., Gray, S. P., & Jandeleit-Dahm, K. A. M. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.01.006 · Cited by 86
Reactive Oxygen Species in Vascular Formation and Development
Zhou, Y., Yan, H. M., Guo, M., Zhu, J., Xiao, Q., & Zhang, L. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/374963 · Cited by 91
NADPH Oxidases NOXs and DUOXs as Putative Targets for Cancer Therapy
Weyemi, U., Redon, C. E., Parekh, P. R., Dupuy, C., & Bonner, W. M. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611313030013 · Cited by 86
The Quest for Selective Nox Inhibitors and Therapeutics: Challenges, Triumphs and Pitfalls
Cifuentes-Pagano, E., Meijles, D. N., & Pagano, P. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5620 · Cited by 84
Ashino, T., Yamamoto, M. P., Yoshida, T., & Numazawa, S. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300614 · Cited by 84
Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives
Lv, M., Chen, Z., Hu, G., & Li, Q. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.007 · Cited by 84
Chen, C., Puliafito, A., Cox, B. D., Primo, L., Fang, Y., Talia, S. D., & Poss, K. D. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.02.017 · Cited by 86
Oxidative Stress Orchestrates Cell Polarity to Promote Embryonic Wound Healing
Hunter, M. V., Willoughby, P. M., Bruce, A. E. E., & Fernández‐González, R. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.10.013 · Cited by 81
Bao, X.-M., Wu, C., & Lu, G.-P. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.11.032 · Cited by 81
Microvascular NADPH oxidase in health and disease
Li, Y., & Pagano, P. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.049 · Cited by 79
How T cells trigger the dissociation of the endothelial receptor phosphatase VE-PTP from VE-cadherin
Vockel, M., & Vestweber, D. (2013) · Blood · doi:10.1182/blood-2013-04-499228 · Cited by 79
Godfrey, R., Arora, D., Bauer, R., Stopp, S., Müller, J. P., Heinrich, T., Böhmer, S., Dagnell, M., Schnetzke, U., Scholl, S., et al. (2012) · Blood · doi:10.1182/blood-2011-02-336446 · Cited by 80
Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation
Dao, V. T.-V., Elbatreek, M. H., Altenhöfer, S., Casas, A. I., Pachado, M. P., Neullens, C. T., Knaus, U. G., & Schmidt, H. H. H. W. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.038 · Cited by 81
Sun, Q.-A., Hess, D. T., Wang, B., Miyagi, M., & Stamler, J. S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.046 · Cited by 76
Inhibiting the Activity of NADPH Oxidase in Cancer
Konaté, M. M., Antony, S., & Doroshow, J. H. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8046 · Cited by 81
Redox‐based therapeutics in neurodegenerative disease
McBean, G. J., López, M. G., & Wallner, F. K. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13551 · Cited by 77
Octavia, Y., Rocca, H. B., & Moens, A. L. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.482 · Cited by 75
Frasier, C. R., Moukdar, F., Patel, H. D., Sloan, R. C., Stewart, L. M., Alleman, R. J., Favor, J. D. L., & Brown, D. A. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt009 · Cited by 76
Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease
Østergaard, J. A., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00749-6 · Cited by 76
NADPH oxidase in stroke and cerebrovascular disease
Tang, X. N., Cairns, B., Kim, J. Y., & Yenari, M. A. (2012) · Neurological Research · doi:10.1179/1743132812y.0000000021 · Cited by 74
Gatto, G. J. J., Ao, Z., Kearse, M. G., Zhou, M., Morales, C. R., Daniels, E., Bradley, B. T., Goserud, M. T., Goodman, K. B., Douglas, S. A., et al. (2011) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2011.636360 · Cited by 76
Margaritelis, N. V., Cobley, J. N., Paschalis, V., Veskoukis, A. S., Theodorou, A. A., Kyparos, A., & Nikolaidis, M. G. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.12.011 · Cited by 74
Touyz, R. M., & Montezano, A. C. I. (2012) · Circulation Research · doi:10.1161/circresaha.112.269068 · Cited by 71
Munnamalai, V., Weaver, C. J., Weisheit, C. E., Venkatraman, P., Agim, Z. S., Quinn, M. T., & Suter, D. M. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12734 · Cited by 70
“To confirm that our previous results were indeed caused by reduced NADPH oxidase activity, we repeated oxidase inhibition experiments with one of the most specific chemical pan-NADPH oxidase inhibitors currently available, VAS2870 (ten Freyhaus et al. 2006; Wind et al. 2010; Altenhofer et al. 2012).”
MethodNADPH oxidase inhibitors: a patent review
Kim, J., Neupane, G. P., Lee, E. S., Jeong, B., Park, B. C., & Thapa, P. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.584870 · Cited by 70
Redox Circuitries Driving Src Regulation
Giannoni, E., & Chiarugi, P. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5525 · Cited by 72
Metadata
- Authors
- TENFREYHAUS, H., HUNTGEBURTH, M., WINGLER, K., SCHNITKER, J., BAUMER, A., VANTLER, M., BEKHITE, M., WARTENBERG, M., SAUER, H., & ROSENKRANZ, S.
- Affiliations
- University of Cologne (DE)
- Vasopharm (Germany) (DE)
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- ROSENKRANZ, S
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07-15
- Volume
- 71
- Issue
- 2
- Pages
- 331-341
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2136386024
- Cited by
- 259
- References
- 46
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 8 · 2022: 7 · 2021: 13 · 2020: 15 · 2019: 15 · 2018: 13 · 2017: 14 · 2016: 9 · 2015: 19 · 2014: 22 · 2013: 24 · 2012: 22
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- VAS2870, platelet-derived growth factor, vascular smooth muscle cells, reactive oxygen species, cell proliferation, Src kinase, Akt, ERK, PDGF signaling, cell migration, DNA synthesis, cardiovascular disease, redox signaling, chemiluminescence, BrdU incorporation, immunofluorescence
- MeSH terms
- Becaplermin, Animals, Aorta, Thoracic, Benzoxazoles, Cell Survival, Cells, Cultured, Chemotaxis, DNA, Enzyme Inhibitors, Muscle, Smooth, Vascular, Platelet-Derived Growth Factor, Rats, Inbred WKY, Triazoles, Blotting, Western, Reactive Oxygen Species, src-Family Kinases, NADPH Oxidases, Proto-Oncogene Proteins c-sis, Myocytes, Smooth Muscle, Immunoprecipitation, Cell Proliferation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
